The vaccine is expected to provide long-lasting protection with a single dose administration with an anticipated safety profile similar to other licensed vaccines for active immunization07 April 2020 Vaccine manufacturer Indian Immunologicals Ltd (IIL) has entered into a research collaboration agreement with Australia’s Griffith University to develop a lead vaccine candidate for Coronavirus. Know more |
Human Biologicals Institute launches Eco Friendly Pack for its Anti Rabies Vaccine ‘Abhayrab’08 January 2020 The new packaging of Abhayrab is manufactured using only paper-based materials which helps in reducing the carbon footprint as well. Know more |
IIL organises animal vaccination camps09 July 2019 Around 50,000 free doses administered by IIL at 170+ Vaccination camps in 20 States & UTs Know more |
Free animal vaccination camps across India by Indian Immunologicals on ‘World Zoonosis Day’09 July 2019 Kolkata, Jul 09 (UNI) Indian Immunologicals Limited (IIL), a leading biologicals company, today organized free Vaccination Camps in over 170 centres across the country. Know more |
Indian Immunologicals to invest Rs 75 cr in sterile facility in Hyderabad24 June 2019 Indian Immunologicals Ltd (IIL), a biologicals company, will invest Rs 75 crore in a new Sterile Filing Facility (SFF), in Phase 3 of the Genome Valley on the outskirts of Hyderabad. Know more |
Indian Immunologicals launches VAXTAR 527 March 2019 Indian Immunologicals Limited has launched VAXTAR 5, Pentavalent vaccine for the children. IIL is all set to make this vaccine in its state-of-the-art vaccine manufacturing facility in Hyderabad for retail market and for the national “Universal Immunisation Programme” (UIP) implemented by Ministry of Health and Family Welfare (MOHFW), Government of India. Know more |
Indian Immunologicals launches herbal product for animals09 January 2018 Indian Immunologicals Ltd (IIL) has launched its first herbal product ‘Zuspray’ for animals. Know more |
Indian manufacturers account for 60% of vaccine supplies made to UNICEF22 August 2017 ‘Indian vaccine manufacturers have several products in their R&D pipeline and as they roll out, the dominance of the multinational companies will subside in the coming years’, says Dr Anand Kumar Managing Director Indian Immunologicals Ltd & Director Pristine Biologicals (NZ) Ltd, in an interaction with BioSpectrum Asia Magazine Know more |